Recombinant Human GEM Protein: Handling & Usage Protocol

Recombinant Human GEM Protein is a GTP-binding protein expressed recombinantly for use in cell signaling research, requiring careful reconstitution and storage to maintain full biological activity.

Product Name

Recombinant Human GEM Protein

SKU

rp370697

Protein Family

GTP-binding protein (Gem/Rad family, small Ras-related GTPase)

Recommended Storage

Store at -20°C or -80°C; avoid repeated freeze-thaw cycles

Application

Cell signaling studies, protein interaction assays, functional biochemical research

Supplier Reference

absea#PP-4925

Overview of Recombinant Human GEM Protein

GEM (GTP-binding protein overexpressed in skeletal muscle) is a member of the Rem/Rad/Gem/Kir (RGK) subfamily of Ras-related small GTPases. It plays critical roles in regulating voltage-gated calcium channel activity, cytoskeletal reorganization, and cell signaling cascades. The recombinant form of Human GEM Protein (SKU: rp370697, supplier reference absea#PP-4925) is produced under controlled conditions to ensure high purity and biological activity suitable for in vitro research applications.

This protein is relevant to studies involving cardiac and skeletal muscle physiology, cancer biology, and signal transduction pathways. Researchers should consult the product datasheet for lot-specific purity, molecular weight, and activity data before proceeding with experimental use.

Materials and Equipment Required

Before beginning reconstitution and handling of Recombinant Human GEM Protein, ensure the following materials and equipment are available:

• Recombinant Human GEM Protein (rp370697), freshly thawed on ice
• Sterile deionized water or the reconstitution buffer specified on the product datasheet
• Phosphate-buffered saline (PBS), pH 7.4, sterile-filtered
• Low-protein-binding microcentrifuge tubes (1.5 mL)
• Micropipettes and calibrated tips
• Benchtop microcentrifuge
• Ice bucket and wet ice
• Protein concentration measurement system (e.g., BCA or Bradford assay kit)
• Appropriate downstream assay reagents (e.g., pull-down, ELISA, or kinase assay components as applicable)

All procedures should be performed on ice or at 4°C unless otherwise specified to preserve protein integrity.

Step-by-Step Reconstitution and Handling Protocol

Follow these steps carefully to ensure optimal protein performance:

1. Thawing: Remove the vial from -80°C (or -20°C) storage and allow it to thaw slowly on ice for 10–15 minutes. Do not thaw at room temperature or use a water bath, as rapid temperature changes may reduce activity.
2. Brief centrifugation: Gently spin the vial at low speed (approximately 500–1000 × g for 30 seconds) to collect any condensate from the cap and walls of the vial before opening.
3. Reconstitution: If supplied lyophilized, reconstitute with the volume of sterile water or buffer specified on the product datasheet. Add the diluent slowly along the vial wall; do not pipette directly onto the lyophilized cake. Gently swirl or invert the vial to dissolve — do not vortex.
4. Concentration verification: After reconstitution, measure protein concentration using a BCA or Bradford assay and compare against the stated concentration on the Certificate of Analysis (CoA).
5. Aliquoting: Prepare single-use aliquots in low-protein-binding tubes to minimize freeze-thaw cycles. Aliquot volumes should match the amount required per experiment.
6. Storage of reconstituted protein: Store aliquots at -80°C for long-term use or at -20°C for short-term use (up to 1 month). Add a carrier protein such as 0.1% BSA if the working concentration is very low (<10 µg/mL) to prevent adsorption losses.
7. Working dilutions: Prepare working dilutions immediately before use in the appropriate assay buffer. Consult the datasheet for recommended concentration ranges specific to your application.

Note: Specific reconstitution volumes, buffer compositions, and working concentrations must be confirmed from the lot-specific product datasheet provided with shipment.

Quality Control and Troubleshooting

To ensure data reliability, implement the following quality control measures and refer to the troubleshooting guidance below if issues arise:

Quality Control Checks

• Confirm protein integrity by SDS-PAGE before use; compare band size against the expected molecular weight noted on the CoA.
• Verify absence of visible aggregation or turbidity in the reconstituted solution; if present, briefly spin at 10,000 × g for 5 minutes at 4°C to pellet aggregates before use.
• Include a positive control (e.g., known-active lot of the same protein if available) in functional assays to validate assay performance.

Common Issues and Solutions

• Loss of activity: Most commonly caused by repeated freeze-thaw cycles or improper storage temperature. Use freshly thawed, single-use aliquots.
• Protein aggregation: May result from over-concentration, incompatible buffer conditions, or vortexing. Centrifuge to remove aggregates and optimize buffer pH and ionic strength.
• Inconsistent results: Verify that the working concentration is within the linear range of your assay. Recalibrate pipettes and confirm reagent lot consistency.
• Low recovery after reconstitution: Ensure all lyophilized material has dissolved fully. Allow additional gentle mixing time and confirm diluent compatibility with the protein formulation.

Safety, Disposal, and Regulatory Considerations

Recombinant Human GEM Protein is intended for research use only (RUO) and is not approved for diagnostic, therapeutic, or clinical use in humans or animals.

• Personal Protective Equipment (PPE): Wear appropriate laboratory PPE, including nitrile gloves, a laboratory coat, and eye protection when handling this reagent.
• Biohazard considerations: Although this is a recombinant protein produced in a defined expression system, handle according to your institution's biosafety guidelines for recombinant proteins (typically BSL-1 practices).
• Disposal: Dispose of all protein-containing waste in accordance with local institutional and governmental regulations for biological materials. Inactivate waste by autoclaving or appropriate chemical treatment before disposal where required.
• SDS/Safety Data Sheet: Consult the Safety Data Sheet (SDS) available from Aladdin Scientific for complete hazard information. Contact Aladdin Scientific support if you require additional safety documentation.

For shipping, storage temperature compliance, and import/export regulatory requirements, refer to Aladdin Scientific's shipping and delivery policies or contact customer service.

Frequently asked questions

What is the recommended reconstitution buffer for Recombinant Human GEM Protein?

The reconstitution buffer and volume are specified on the lot-specific Certificate of Analysis (CoA) and product datasheet supplied with each order. Generally, sterile PBS (pH 7.4) or deionized water is commonly used for recombinant proteins, but always confirm with the datasheet for this specific product (rp370697) to avoid activity loss.

How many freeze-thaw cycles can Recombinant Human GEM Protein tolerate?

To maintain maximum biological activity, it is strongly recommended to limit freeze-thaw cycles to an absolute minimum — ideally zero after the initial thaw. Prepare single-use aliquots upon first thaw and store unused aliquots at -80°C. Repeated freeze-thaw cycles can cause protein denaturation, aggregation, and significant loss of activity.

What applications is Recombinant Human GEM Protein validated for?

Recombinant Human GEM Protein (rp370697) is intended for in vitro research applications including protein-protein interaction studies, biochemical assays, and cell signaling research. Specific validated applications and recommended working concentrations are detailed on the product datasheet. Researchers should independently validate the protein's performance in their specific experimental system.

How should I handle Recombinant Human GEM Protein if I notice aggregation after thawing?

If aggregation or turbidity is observed after thawing, centrifuge the sample at 10,000 × g for 5 minutes at 4°C to pellet aggregates, then carefully transfer the clear supernatant to a fresh low-protein-binding tube. Avoid using aggregated material in sensitive assays, as it may yield inconsistent results and could affect downstream data quality.

Is Recombinant Human GEM Protein suitable for in vivo or clinical use?

No. Recombinant Human GEM Protein (rp370697) is strictly for research use only (RUO) and is not intended for diagnostic, therapeutic, or clinical applications in humans or animals. Use in any non-research context is outside the product's intended scope and regulatory clearance.

References

1. Yanagisawa H, et al. GEM, a GTP-binding protein of the RGK subfamily, regulates calcium channel activity. (General reference — confirm specific publication details from primary literature.)
2. Bhatt DL, et al. RGK proteins: structure, function, and role in signaling. (General textbook-level reference — verify specific authors, journal, and year before publication.)
3. Aladdin Scientific. Recombinant Human GEM Protein (rp370697) Product Datasheet. Aladdin Scientific; [current year]. Supplier reference: absea#PP-4925.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.